Design and synthesis of novel selective estrogen receptor degradation inducers based on the diphenylheptane skeleton

Takashi Misawa1, Takuma Fujisato1, Yasunari Kanda1

  • 1National Institute of Health Sciences Setagaya , Tokyo , 158-8501 , Japan . Email: misawa@nihs.go.jp ;

Medchemcomm
|August 16, 2018
PubMed

Insights

Researchers developed a novel drug, PBP-NC10, that targets and degrades estrogen receptor alpha (ERα) in breast cancer cells. This selective ER degrader works via the ubiquitin-proteasome system, offering a new therapeutic strategy for hormone-dependent cancers.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Estrogen receptors (ERs) are nuclear receptors regulating key physiological processes.
  • Approximately 70% of human breast cancers are ERα-positive and hormone-dependent.
  • Novel therapeutic strategies targeting ERs are crucial for breast cancer treatment.

Purpose of the Study:

  • To design and synthesize a novel selective estrogen receptor degrader (SERD).
  • To investigate the mechanism of action of the synthesized compound on ERα.
  • To predict the binding interactions of the compound with ERα.

Main Methods:

  • Chemical synthesis of a diphenylheptane-based compound.
  • Western blotting to analyze protein degradation.
  • Computational docking to predict binding modes.

Main Results:

  • A selective ERα degradation inducer, PBP-NC10, was successfully synthesized.
  • Western blotting confirmed that PBP-NC10 degrades ERα via the ubiquitin-proteasome system.
  • Computational docking provided insights into the binding mode of PBP-NC10 to ERα.

Conclusions:

  • PBP-NC10 is a novel selective ERα degrader with potential therapeutic applications.
  • The ubiquitin-proteasome system is the mechanism by which PBP-NC10 induces ERα degradation.
  • Further studies are warranted to explore PBP-NC10 as an anti-breast cancer agent.

Related Concept Videos

Carbon Skeletons01:12

Carbon Skeletons

Life on Earth is carbon-based, as all macromolecules that make up living organisms contain carbon atoms. All organic compounds have a carbon backbone. Each carbon atom is tetravalent and can bond with four other atoms, making it an extraordinarily flexible component of biological molecules. Because carbon’s valence electrons are stable, it rarely becomes an ion. As the carbon chain increases in length, structural modifications such as ring structures, double bonds, and branching side...
115.3K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
74.7K
Proteins: From Genes to Degradation02:11

Proteins: From Genes to Degradation

Within a biological system, the DNA encodes the RNA, and the nucleotide sequence in the RNA further defines the amino acid sequence in the protein. This is referred to as “The Central Dogma of Molecular Biology” - a term coined by Francis Crick.  Central dogma is a firm principle in biology that defines the flow of genetic information within any life form. The two fundamental steps in central dogma are - transcription and translation.
Transcription is the synthesis of RNA...
14.5K